Remimazolam
Sleeve Gastrectomy
Seoul National University Bundang HospitalSmall moleculePhase 4 / ApprovedActive
BB
65/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 50/ 100
- Competitive Position
- 95/ 100
Competitive context
3 Active assets in the Sleeve Gastrectomy cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Zofran Tanta University | Phase 3 | B |
CYCLOHEXANEACETIC ACID, 1-(AMINOMETHYL)- Tanta University | Phase 3 | B |
Iron Cairo University | D |
Same molecule, other indications
Remimazolam is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →